EE354 Value for Money: Evaluating the Economic Benefit of a Hypothetical Disease Modifying Therapy for Alzheimer's Disease From Canadian Payer and Societal Perspectives
Abstract
Authors
T. Maity J. Haig N.A. Kulin
T. Maity J. Haig N.A. Kulin
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now